Vertex Pharmaceuticals Inc / Ma
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/29/2026 | 31,383 | 0.2% | 69,223 | 12/31/2025 |
| 2025 Q3 | 11/5/2025 | 28,207 | 0.1% | 72,023 | 9/30/2025 |
| 2025 Q2 | 8/5/2025 | 32,287 | 0.2% | 72,523 | 6/30/2025 |
| 2025 Q1 | 4/30/2025 | 34,967 | 0.2% | 72,123 | 3/31/2025 |
| 2024 Q4 | 2/6/2025 | 29,165 | 0.2% | 72,423 | 12/31/2024 |
| 2024 Q3 | 11/4/2024 | 34,241 | 0.2% | 73,623 | 9/30/2024 |
| 2024 Q2 | 7/26/2024 | 34,649 | 0.2% | 73,923 | 6/30/2024 |
| 2024 Q1 | 4/18/2024 | 30,566 | 0.2% | 73,123 | 3/31/2024 |
| 2023 Q4 | 1/23/2024 | 29,712 | 0.2% | 73,023 | 12/31/2023 |
| 2023 Q3 | 10/27/2023 | 25,358 | 0.2% | 72,923 | 9/30/2023 |
| 2023 Q2 | 7/26/2023 | 25,873 | 0.2% | 73,523 | 6/30/2023 |
| 2023 Q1 | 4/28/2023 | 23,259 | 0.2% | 73,823 | 3/31/2023 |
| 2022 Q4 | 1/27/2023 | 21,059 | 0.1% | 72,923 | 12/31/2022 |
| 2022 Q3 | 10/24/2022 | 21,259 | 0.2% | 73,423 | 9/30/2022 |
| 2022 Q2 | 8/8/2022 | 20,577 | 0.1% | 73,023 | 6/30/2022 |
| 2022 Q1 | 5/4/2022 | 16,760 | 0.1% | 64,223 | 3/31/2022 |
| 2021 Q4 | 1/27/2022 | 14,062 | 0.1% | 64,034 | 12/31/2021 |
| 2021 Q3 | 10/27/2021 | 11,815 | 0.1% | 65,134 | 9/30/2021 |
| 2021 Q2 | 7/27/2021 | 13,113 | 0.1% | 65,034 | 6/30/2021 |
| 2021 Q1 | 7/27/2021 | 14,018 | 0.1% | 65,234 | 3/31/2021 |
| 2020 Q4 | 7/27/2021 | 15,465 | 0.1% | 65,434 | 12/31/2020 |
| 2020 Q3 | 10/26/2020 | 50,052 | 0.4% | 183,934 | 9/30/2020 |
| 2020 Q2 | 7/29/2020 | 47,447 | 0.4% | 163,434 | 6/30/2020 |
| 2020 Q1 | 5/1/2020 | 34,019 | 0.4% | 142,968 | 3/31/2020 |
| 2019 Q4 | 1/24/2020 | 32,003 | 0.3% | 146,168 | 12/31/2019 |
| 2014 Q2 | 8/6/2014 | 9,165 | 0.1% | 96,800 | 6/30/2014 |
| 2014 Q1 | 5/6/2014 | 6,803 | 0.1% | 96,200 | 3/31/2014 |
| 2013 Q4 | 2/7/2014 | 7,058 | 0.1% | 95,000 | 12/31/2013 |